Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Strategy for circulatory disturbance].

S Uchiyama1, M Yamazaki, M Iwata

  • 1Department of Neurology, Neurological Institute, Tokyo Women's Medical University.

Rinsho Shinkeigaku = Clinical Neurology
|September 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Preparation and utility of glibenclamide suppository for hospital use].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·1998
Same author

Induction of thymocyte apoptosis by Ca2+-independent protein kinase C (nPKC) activation and its regulation by calcineurin activation.

The Journal of biological chemistry·1998
Same author

Familial amyotrophic lateral sclerosis with widespread vacuolation and hyaline inclusions.

Neurology·1998
Same author

Progressive aphemia in a patient with Pick's disease: a neuropsychological and anatomic study.

Journal of the neurological sciences·1998
Same author

Pattern reversal visual evoked potentials in migraine with aura and migraine aura without headache.

Cephalalgia : an international journal of headache·1998
Same author

Circadian rhythm of breath hydrogen in young women.

Journal of gastroenterology·1998

Thrombolytic therapy for acute ischemic stroke offers benefits in reducing disability but carries risks of hemorrhage. Newer agents and aspirin show promise, while anticoagulants have not demonstrated clear net benefits.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Acute ischemic stroke presents significant morbidity and mortality.
  • Effective treatments aim to restore blood flow and minimize brain damage.
  • Thrombolytic and anticoagulant therapies are key areas of investigation.

Purpose of the Study:

  • To review the efficacy and safety of various pharmacological interventions for acute ischemic stroke.
  • To evaluate the net benefit of thrombolytic and anticoagulant therapies.
  • To explore emerging treatments including newer thrombolytics, anticoagulants, and antiplatelet agents.

Main Methods:

  • Meta-analysis of existing trials on thrombolytic therapy (Cochrane Stroke Group).
  • Review of trials investigating intravenous (i.v.) tissue plasminogen activator (tPA).

Related Experiment Videos

  • Analysis of studies on intra-arterial pro-urokinase, anticoagulants, aspirin, and abciximab.

    • Main Results:

    • Thrombolytic therapy reduces disability but increases hemorrhage risk; overall net benefit observed.
    • Intravenous tPA may offer a better risk-benefit profile.
    • Anticoagulant therapy showed no clear net short or long-term benefit.
    • Aspirin demonstrated a modest effect in reducing death or dependency.
    • Emerging agents like pro-urokinase and argatroban show potential in specific patient groups.

    Conclusions:

    • Thrombolytic therapy provides a net reduction in death or dependency despite increased hemorrhage risks.
    • Further research into third-generation thrombolytics and agents like abciximab is ongoing.
    • Current evidence does not support routine anticoagulant therapy for acute ischemic stroke, though specific agents may benefit subgroups.